ANI Pharmaceuticals develops, manufactures, and markets branded and generic prescription pharmaceuticals in the US and Canada. It produces oral solids, semi-solids, liquids, topicals, controlled substances, and potent products. The company also provides contract development and manufacturing services. Products are marketed through various channels, including retail pharmacy chains, wholesalers, and mail order pharmacies. ANI was incorporated in 2001 and is headquartered in Minnesota.
| Indicator | Value |
|---|---|
| PER | 100.0 |
| EV/EBITDA | 28.2 |
| Price/Free Cash Flow' | 29.4 |
| ROIC | 6.1% |
| Net Debt/EBITDA | 7.3 |